Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34965417)

  • 1. Human iPSC-derived fallopian tube organoids with BRCA1 mutation recapitulate early-stage carcinogenesis.
    Yucer N; Ahdoot R; Workman MJ; Laperle AH; Recouvreux MS; Kurowski K; Naboulsi DJ; Liang V; Qu Y; Plummer JT; Gayther SA; Orsulic S; Karlan BY; Svendsen CN
    Cell Rep; 2021 Dec; 37(13):110146. PubMed ID: 34965417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Fallopian Tube-Derived Organoids with TP53 and RAD51D Mutations Recapitulate an Early Stage High-Grade Serous Ovarian Cancer Phenotype In Vitro.
    Dai Y; Xu J; Gong X; Wei J; Gao Y; Chai R; Lu C; Zhao B; Kang Y
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma.
    Zhang S; Dolgalev I; Zhang T; Ran H; Levine DA; Neel BG
    Nat Commun; 2019 Nov; 10(1):5367. PubMed ID: 31772167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of γ-H2AX and p53 nuclear expression levels in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies in BRCA1 and BRCA2 mutation carriers.
    Staff S; Tolonen T; Laasanen SL; Mecklin JP; Isola J; Mäenpää J
    Int J Gynecol Pathol; 2014 May; 33(3):309-16. PubMed ID: 24681744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F3b over-expression in ovarian carcinomas and in BRCA1 haploinsufficient fallopian tube epithelium.
    Smith NL; Welcsh P; Press JZ; Agnew KJ; Garcia R; Swisher EM
    Genes Chromosomes Cancer; 2012 Nov; 51(11):1054-62. PubMed ID: 22887716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A putative role for ALDH inhibitors and chemoprevention of BRCA-mutation-driven tumors.
    McGonigal S; Wu R; Grimley E; Turk EG; Zhai Y; Cho KR; Buckanovich RJ
    Gynecol Oncol; 2023 Sep; 176():139-146. PubMed ID: 37535994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution.
    Bartlett TE; Chindera K; McDermott J; Breeze CE; Cooke WR; Jones A; Reisel D; Karegodar ST; Arora R; Beck S; Menon U; Dubeau L; Widschwendter M
    Nat Commun; 2016 May; 7():11620. PubMed ID: 27216078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation in the normal FTE is a hallmark of the follicular phase, not BRCA mutation status.
    George SH; Milea A; Shaw PA
    Clin Cancer Res; 2012 Nov; 18(22):6199-207. PubMed ID: 22967960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies.
    Hellner K; Miranda F; Fotso Chedom D; Herrero-Gonzalez S; Hayden DM; Tearle R; Artibani M; Carrami EM; Williams R; Gaitskell K; Elorbany S; Xu R; Laios A; Buiga P; Ahmed K; Dhar S; Zhang RY; Campo L; Myers KA; Lozano M; Ruiz-Miró M; Gatius S; Mota A; Moreno-Bueno G; Matias-Guiu X; Benítez J; Witty L; McVean G; Leedham S; Tomlinson I; Drmanac R; Cazier JB; Klein R; Dunne K; Bast RC; Kennedy SH; Hassan B; Lise S; Garcia MJ; Peters BA; Yau C; Sauka-Spengler T; Ahmed AA
    EBioMedicine; 2016 Aug; 10():137-49. PubMed ID: 27492892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.
    Nolan E; Vaillant F; Branstetter D; Pal B; Giner G; Whitehead L; Lok SW; Mann GB; ; Rohrbach K; Huang LY; Soriano R; Smyth GK; Dougall WC; Visvader JE; Lindeman GJ
    Nat Med; 2016 Aug; 22(8):933-9. PubMed ID: 27322743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Directed Differentiation of Human Induced Pluripotent Stem Cells into Fallopian Tube Epithelium.
    Yucer N; Holzapfel M; Jenkins Vogel T; Lenaeus L; Ornelas L; Laury A; Sareen D; Barrett R; Karlan BY; Svendsen CN
    Sci Rep; 2017 Sep; 7(1):10741. PubMed ID: 28878359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progestin Significantly Inhibits Carcinogenesis in the Mogp-TAg Transgenic Mouse Model of Fallopian Tube Cancer.
    Nelson OL; Rosales R; Turbov JM; Thaete LG; Cline JM; Rodriguez GC
    Cancer Prev Res (Phila); 2022 Feb; 15(2):75-86. PubMed ID: 34844992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment.
    Hoffmann K; Berger H; Kulbe H; Thillainadarasan S; Mollenkopf HJ; Zemojtel T; Taube E; Darb-Esfahani S; Mangler M; Sehouli J; Chekerov R; Braicu EI; Meyer TF; Kessler M
    EMBO J; 2020 Mar; 39(6):e104013. PubMed ID: 32009247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis.
    Yates MS; Meyer LA; Deavers MT; Daniels MS; Keeler ER; Mok SC; Gershenson DM; Lu KH
    Cancer Prev Res (Phila); 2011 Mar; 4(3):463-70. PubMed ID: 21278312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the tumorigenic potential of genetic interactions reconstituted in murine fallopian tube organoids.
    Maru Y; Tanaka N; Tatsumi Y; Nakamura Y; Yao R; Noda T; Itami M; Hippo Y
    J Pathol; 2021 Oct; 255(2):177-189. PubMed ID: 34184756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. iPSC-Derived Hereditary Breast Cancer Model Reveals the
    Portier L; Desterke C; Chaker D; Oudrhiri N; Asgarova A; Dkhissi F; Turhan AG; Bennaceur-Griscelli A; Griscelli F
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation.
    Russo A; Czarnecki AA; Dean M; Modi DA; Lantvit DD; Hardy L; Baligod S; Davis DA; Wei JJ; Burdette JE
    Oncogene; 2018 Apr; 37(15):1976-1990. PubMed ID: 29367766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation patterns in fallopian tube epithelium of BRCA1 and BRCA2 germ line mutation carriers.
    Bijron JG; van der Groep P; van Dorst EB; Seeber LM; Sie-Go DM; Verheijen RH; van Diest PJ
    Endocr Relat Cancer; 2012 Feb; 19(1):69-81. PubMed ID: 22143498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oncopathological aspects of BRCA1 and BRCA2 genes inactivation in tumors of ovary, fallopian tube and pelvic peritoneum].
    Škapa P; Dundr P
    Cesk Patol; 2016; 52(4):199-204. PubMed ID: 27869446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a preneoplastic gene expression profile in tubal epithelium of BRCA1 mutation carriers.
    Press JZ; Wurz K; Norquist BM; Lee MK; Pennil C; Garcia R; Welcsh P; Goff BA; Swisher EM
    Neoplasia; 2010 Dec; 12(12):993-1002. PubMed ID: 21170264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.